United States

Jiangsu Hengrui Medicine Co Ltd (600276.SS)

600276.SS on Shanghai Stock Exchange

16 Aug 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


JIANSU HENGRUI MEDICINE CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty... (more)


Beta: 0.46
Market Cap(Mil.): ¥248,675.30
Shares Outstanding(Mil.): 3,682.44
Dividend: 0.10
Yield (%): 0.15


  600276.SS Industry Sector
P/E (TTM): 69.55 28.12 30.20
EPS (TTM): 0.97 -- --
ROI: 23.58 13.07 12.77
ROE: 23.12 15.04 14.92

BRIEF-Jiangsu Hengrui Medicine unit passes U.S. FDA approval

* Says co's unit Shanghai Hengrui Pharmaceutical Co Ltd received FDA approval for desflurane for inhalation (product) from U.S. Food and Drug Administration

Mar 01 2018

BRIEF-Jiangsu Hengrui Medicine receives GMP certificate

* Says it received goods manufacture practice (GMP) certificate from Health and Youth Care Inspectorate

Feb 28 2018

Earnings vs. Estimates